Abstract:Background: Neurologic impediments occur in only 0.1% of Mycoplasma pneumoniae infections. Although direct intracerebral infection can occur in these patients, autoimmune-mediated reactions secondary to molecular mimicry are the most common pathophysiology of such neurological complications. These complications include immune-mediated encephalitis, peripheral neuritis such as Guillain-Barré syndrome, and many others. Miller Fisher syndrome is a one of the variants of Guillain-Barré syndrome that has been rarely linked to Mycoplasma pneumoniae infection. It is a condition classically characterized by the triad of ophthalmoplegia, areflexia, and ataxia. Most patients with Miller Fisher syndrome will have positive anti-ganglioside GQ1b antibodies found in their serum, making this autoantibody a very useful serological confirmation parameter. We report a case of a Miller Fisher syndrome in a woman with Mycoplasma pneumoniae infection. To the best of the authors' knowledge, such cases have been only rarely described in literature. Case presentation: A 35-year-old Chinese woman presented with sudden onset of double vision and ataxia 5 days after fever and mild flu symptoms. Her Mycoplasma pneumoniae antigen was positive with 1 over 2560 titer of total mycoplasma antibody and presence of immunoglobulin M antibody, suggesting acute infection, and her nerve conduction study revealed mild sensory axonal polyneuropathy with segmental demyelination. the Miller Fischer syndrome variant of Guillain-Barré syndrome secondary to Mycoplasma pneumonia was suspected and later confirmed by presence of serum anti-GQ1b autoantibody. She was treated with intravenous immunoglobulin 0.4 g/kg once daily for 5 days. Conclusions: The objective of this report is to share a case of an uncommon neurological complication of Mycoplasma pneumoniae infection, to increase the level of suspicion among clinicians that Miller Fischer syndrome can occur as an atypical presentation of an atypical pneumonia.

Acute motor axonal neuropathy after Mycoplasma infection: Evidence of molecular mimicry

Reversible Bilateral Striatal Lesions Following Mycoplasma Pneumoniae Infection Associated with Elevated Levels of Interleukins 6 and 8.

Antibodies to Glycolipids in Guillain-Barré Syndrome, Miller Fisher Syndrome and Related Autoimmune Neurological Diseases

Anti-Ganglioside Antibodies In Guillain- Barre Syndrome And Chronic Inflammatory Demyelinating Polyneuropathy In Chinese Patients

P.055 Bilateral facial nerve gadolinium enhancement and GBS

Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome

Campylobacter jejuni Infection, Anti-Ganglioside Antibodies, and Neuropathy

Atypical presentation of an atypical pneumonia: a case report

On-Membrane Dynamic Interplay between Anti-GM1 IgG Antibodies and Complement Component C1q

Ambiguous value of anti-ganglioside IgM autoantibodies in Guillain-Barré syndrome and its variants

Claw Hand in Acute Motor Axonal Neuropathy Variant

The clinical features of patients concurrent with Guillain-Barre syndrome and myasthenia gravis.

Delayed motor and sensory neuropathy in a patient with brainstem encephalitis

Only anti-GM4 antibody positivity in a Chinese girl with overlapping MFS/GBS: a case report

IgM anti-GM2 antibodies in patients with multifocal motor neuropathy target Schwann cells and are associated with early onset

Acute motor axonal neuropathy in association with Sjögren syndrome

SARS-CoV-2-associated Guillain-Barré syndrome in four patients: what do we know about pathophysiology?

Evidence for spontaneous regulation of the humoral IgM anti-GM1 autoimmune response by IgG antibodies in multifocal motor neuropathy patients

Detection of anti-ganglioside antibodies in Guillain-Barré syndrome

Campylobacter jejuni induces autoimmune peripheral neuropathy via Sialoadhesin and Interleukin-4 axes

Optic neuritis and palatal dysarthria as presenting features of post-infectious GQ1b antibody syndrome